Singapore, Sept. 15 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED made the following announcement:
Security Name: NA
General Announcement::U.S. FDA Accepts New Drug Application Under Priority Review for Takeda Zasocitinib (https://links.sgx.com/1.0.0/corporate-announcements/PP71FFUPJUMDABVU/ddfbb358e3cf9e9842277d4b2e235e84a83fdd7d9dd2da7095c029f485c00d42)
Published by HT Digital Content Services with permission from South East Asian News....